This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: University of South Florida, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2019-2026.
Company Filing History:
4 out of 1,985 
1 out of 955 
Years Active: 2019-2026
Title: Kevin Ron Nash: Innovator in Gene Therapy and Neuroinflammation Treatment
Introduction
Kevin Ron Nash is a notable inventor based in Seffner, FL (US). He has made significant contributions to the field of gene therapy and neuroinflammation treatment, holding a total of 4 patents. His work focuses on addressing complex genetic disorders and neurodegenerative diseases, showcasing his commitment to advancing medical science.
Latest Patents
One of Nash's latest patents involves a modified UBE3A gene for a gene therapy approach to Angelman Syndrome (AS). This genetic disorder affects approximately one in every 15,000 births and is characterized by severe mental retardation, seizures, difficulty speaking, and ataxia. The UBE3A gene, responsible for AS, encodes for E6-AP, an ubiquitin ligase that undergoes maternal imprinting in a neuron-specific manner. Nash's innovative approach includes generating a Ube3a protein with additional sequences to facilitate secretion from cells and uptake by neighboring neuronal cells, potentially rescuing disease pathology.
Another significant patent pertains to the recombinant adeno-associated virus-mediated expression of fractalkine for treating neuroinflammatory and neurodegenerative diseases. This invention focuses on using fractalkine (FKN, CX3CL1) and its receptor CX3CR1 to address conditions such as Parkinson's disease, Alzheimer's disease, epilepsy, aging, and traumatic brain injury. The method involves administering an adeno-associated virus containing a functional fractalkine gene to cells in need of treatment.
Career Highlights
Throughout his career, Nash has worked with esteemed organizations, including the University of South Florida and the United States Government as represented by the Department of Veterans Affairs. His experience in these institutions has allowed him to contribute to groundbreaking research and development in his field.
Collaborations
Nash has collaborated with notable colleagues, including Carmelina Gemma and Edwin John Weeber. These partnerships have further enriched his research endeavors and have played a crucial role in advancing his innovative projects.
Conclusion
Kevin Ron Nash is a pioneering inventor whose work in gene therapy and neuroinflammation treatment has the potential to transform the lives of individuals affected by genetic disorders and neurodegenerative diseases. His contributions to science and medicine are commendable and reflect his dedication to innovation.